SEngine Precision Medicine

📍 Seattle, United States👥 19 employees💰 Last funded Oct 2018
Biotechnology Research🌐 senginemedicine.com
Website LinkedIn
SEngine Precision Medicine brings the latest advances in cancer research and treatment to the fight against cancer. With a focus on functional screening, genomics, robotics, cancer organoid cultures, and bioinformatics, SEngine Precision Medicine is providing invaluable data to oncologists and realizing the promise of precise, less toxic and more effective therapies to cancer patients. The accumulation of data is essential to pharmaceutical companies to accelerate the success of cancer treatments. SEngine is CLIA certified to receive your sample today.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in SEngine Precision Medicine?
SEngine Precision Medicine has 1 investors on record on gritt.io.
When did SEngine Precision Medicine last raise funding?
The most recent investment in SEngine Precision Medicine recorded on gritt.io was in October 2018.
What industry is SEngine Precision Medicine in?
SEngine Precision Medicine operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SEngine Precision Medicine based?
SEngine Precision Medicine is headquartered in Seattle, United States.